Shares of Sarepta Therapeutics fell close to 37% on Friday after reports emerged that the US Food and Drug Administration is considering whether to halt the distribution of Elevidys, the company’s flagship gene therapy for Duchenne Muscular Dystrophy (DMD). The move comes amid an ongoing investigation into multiple patient deaths…
Talen Energy (NYSE: TLN) shares surged over 25% on Friday, reaching $330.99 in intraday trading and setting a new…
Donald Trump filed a sweeping lawsuit against media magnate Rupert Murdoch, News Corp, Dow Jones, and two Wall Street…
In a sweeping reform of the UK’s democratic process, the Government has confirmed that 16- and 17-year-olds will be…
Jaguar Land Rover (JLR) is preparing to slash up to 500 management roles in the UK, citing mounting pressure…
The UK’s national debt has quietly shrunk by millions of pounds after an unexpected move by a little-known government…
Amazon Web Services (AWS), the cloud computing wing of Amazon, laid off several hundred employees on Thursday as part…
Japan’s key measure of consumer prices cooled slightly more than expected in June, but remained well above the Bank…
Israel’s stock market has defied the odds to become the strongest performer in the Middle East over the past…